List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Age or weight restriction:
Hydrocortisone preferred in neonates. Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III)). |
Bolivia | LINAME 2011 - 2013 | No observations |
Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
List | Section | Observation |
---|---|---|
Colombia | 10.5 Corticosteroids | No observations |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |
List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |
List | Section | Observation |
---|---|---|
Colombia | 08.3 Systemic Corticosteroids | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Age or weight restriction:
Hydrocortisone preferred in neonates. Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III)). |
List | Section | Observation |
---|---|---|
Colombia | 10.5 Corticosteroids | No observations |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |